Prestige Consumer Healthcare FY27 Q1 GAAP diluted EPS drops to $0.61; revenue rises 6.5% to $265.7 million
Reuters2026/08/06 10:09- Prestige Consumer Healthcare posted fiscal 2027 Q1 net income of USD 29.2 million, down from USD 47.5 million a year earlier; diluted EPS fell to USD 0.61.
- Revenue rose 6.5% year over year to USD 265.7 million, helped by gastrointestinal and dermatological strength; Breathe Right added USD 5.9 million.
- GAAP operating income slid to USD 52.5 million from USD 71.8 million; interest expense, net climbed to USD 13.9 million from USD 10.2 million.
- Adjusted diluted EPS increased to USD 0.98 from USD 0.95, reflecting non-GAAP add-backs tied mainly to acquisition-related costs.
- Raised fiscal 2027 outlook to include acquisitions, targeting revenue of USD 1.29 billion to USD 1.32 billion; adjusted diluted EPS seen at USD 4.55 to USD 4.65.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British banks "offload risk" for cash: high-risk retail loan collateral surges twofold in a single week
According to disclosure documents from the Bank of England, British commercial banks are increasingly using high-risk assets—such as loans related to high-interest department store credit cards and car leasing—as collateral pledged to the Bank of England.
Mitsubishi Heavy Industries, NEC form strategic defense alliance
TagMaster unit Citilog deploys AI incident detection system on Greece’s Egnatia Motorway
Rheinmetall unit wins USD 710,000 order from Kongsberg for US Marine vehicle program components
Crypto prices
More
